Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products > 57 > 

57-33-0

Products Categories

Basic Information
CAS No.: 57-33-0
Name: Pentobarbital sodium
Article Data: 2
Molecular Structure:
Molecular Structure of 57-33-0 (Pentobarbital sodium)
Formula: C11H18N2NaO3
Molecular Weight: 248.257
Synonyms: Barbituric acid,5-ethyl-5-(1-methylbutyl)-, sodium salt (7CI,8CI);5-Ethyl-5-(1-methylbutyl)barbituric acid sodium salt;Auropan;Biosedan;Diabutal;Ethaminal sodium;Euthanyl;Isobarb;Mebubarbital sodium;Mebumal sodium;Mebunat;Narcoren;Pacifan;Pentobarbitone sodium;Praecicalm;Sagatal;Sodium5-ethyl-5-(1-methylbutyl)barbiturate;Sodium ethaminal;Sodiumpental;Sodium pentobarbitone;Sodium-Pent;Soluble pentobarbital;Sopental;Sotyl;V-Pento;Pentobarbital sodium;
EINECS: 200-323-9
Melting Point: 127 °C (decomp)
Solubility: Soluble in water
Appearance: Crystalline granules or white powder
Hazard Symbols: ToxicT
Risk Codes: 25
Safety: 45
Transport Information: UN 2811 6.1/PG 3
PSA: 81.59000
LogP: 1.02630
  • Display:default sort

    New supplier

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

Specification

The IUPAC name of Pentobarbital sodium is 5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione; sodium. With the CAS registry number 57-33-0, it is also named as 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, monosodium salt. Pentobarbital sodium occurs as odorless, slightly bitter tasting, white, crys­talline powder or granules. It is very soluble in water and freely soluble in alcohol. The pKa of the drug has been reported to range from 7.85-8.03 and the pH of the injection is from 9-10.5. Alcohol or propylene glycol may be added to enhance the stability of the in­jectable product.

Physical properties about Pentobarbital sodium are: (1)ACD/LogP: 2.05; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 2; (4)ACD/LogD (pH 7.4): 2; (5)ACD/BCF (pH 5.5): 21; (6)ACD/BCF (pH 7.4): 16; (7)ACD/KOC (pH 5.5): 310; (8)ACD/KOC (pH 7.4): 235; (9)#H bond acceptors: 5; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 4; (12)Rotatable Bond Count: 4; (13)Tautomer Count: 6; (14)Exact Mass: 249.121512; (15)MonoIsotopic Mass: 249.121512; (16)Topological Polar Surface Area: 75.3; (17)Heavy Atom Count: 17.

Uses of Pentobarbital sodium: Once Pentobarbital sodium was the principal agent used for general anesthesia in small animals, but has been largely superceded by the inhalant anesthetic agents. It is still commonly used as an anesthetic in laboratory situations, for rodents and occasionally as a sedative agent in dogs and cats. Pentobarbital sodium is considered to be a drug of choice in dogs and cats for treating intractable seizures secondary to convulsant agents (e.g., strychnine) or as a result of CNS toxins (e.g., tetanus). It should not be used to treat seizures caused by lidocaine intoxication. Pentobarbital sodium has been used as a sedative and anesthetic agent in horses, cattle, swine, sheep and goats. Often the drug is given after a preanesthetic agent to reduce pentobarbital dosages and side effects. Pentobarbital is a major active ingredient in several euthanasia solutions. This indication is discussed later in this section in the monograph for pentobarbital euthanasia solutions.

When you are using this chemical, please be cautious about it as the following:
It is toxic if swallowed. In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)

People can use the following data to convert to the molecule structure:
1. SMILES:[Na+].O=C1NC(=O)NC(=O)C1(C(C)CCC)CC;
2. InChI:InChI=1/C11H18N2O3.Na/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15;/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16);/q;+1;|

The following are the toxicity data which has been tested.

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
bird - wild LD50 oral 75mg/kg (75mg/kg)   Toxicology and Applied Pharmacology. Vol. 21, Pg. 315, 1972.
cat LD50 oral 100mg/kg (100mg/kg) BEHAVIORAL: GENERAL ANESTHETIC

BEHAVIORAL: EXCITEMENT

BEHAVIORAL: ATAXIA
Journal of Pharmacology and Experimental Therapeutics. Vol. 88, Pg. 260, 1946.
cat LDLo intraperitoneal 70mg/kg (70mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 46, Pg. 387, 1932.
chicken LD50 intraperitoneal 51540ug/kg (51.54mg/kg)   Toxicology and Applied Pharmacology. Vol. 2, Pg. 558, 1960.
chicken LD50 intravenous 48mg/kg (48mg/kg)   Toxicology and Applied Pharmacology. Vol. 2, Pg. 558, 1960.
dog LD50 oral 65mg/kg (65mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 80, Pg. 119, 1944.
dog LDLo intraperitoneal 50mg/kg (50mg/kg)   "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973Vol. -, Pg. 181, 1973.
dog LDLo intravenous 50mg/kg (50mg/kg) BEHAVIORAL: GENERAL ANESTHETIC Journal of Pharmacology and Experimental Therapeutics. Vol. 60, Pg. 125, 1937.
duck LD50 oral 75mg/kg (75mg/kg)   Toxicology and Applied Pharmacology. Vol. 21, Pg. 315, 1972.
guinea pig LD50 intramuscular 70300ug/kg (70.3mg/kg) BEHAVIORAL: SLEEP Canadian Anaesthetists' Society Journal. Vol. 2, Pg. 109, 1955.
guinea pig LD50 oral 60mg/kg (60mg/kg)   Compilation of LD50 Values of New Drugs.
guinea pig LD50 subcutaneous 70mg/kg (70mg/kg) AUTONOMIC NERVOUS SYSTEM: PARASYMPATHOLYTIC Archives Internationales de Pharmacodynamie et de Therapie. Vol. 137, Pg. 375, 1962.
guinea pig LDLo intraperitoneal 56mg/kg (56mg/kg)   Proceedings of the Society for Experimental Biology and Medicine. Vol. 33, Pg. 527, 1936.
man TDLo oral 6430ug/kg (6.43mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ATAXIA

BEHAVIORAL: ANTIPSYCHOTIC
Journal of Pharmacology and Experimental Therapeutics. Vol. 197, Pg. 488, 1976.
 
mouse LD50 intracrebral 6500ug/kg (6.5mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 197, Pg. 479, 1976.
mouse LD50 intramuscular 124mg/kg (124mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 102, Pg. 138, 1951.
mouse LD50 intraperitoneal 126mg/kg (126mg/kg)   Journal of Medicinal Chemistry. Vol. 12, Pg. 989, 1969.
mouse LD50 intravenous 81mg/kg (81mg/kg)   European Journal of Pharmacology. Vol. 13, Pg. 150, 1971.
mouse LD50 oral 239mg/kg (239mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 2180, 1981.
mouse LD50 subcutaneous 122mg/kg (122mg/kg)   Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971.
 
pigeon LD50 oral 133mg/kg (133mg/kg)   Toxicology and Applied Pharmacology. Vol. 21, Pg. 315, 1972.
rabbit LD50 intraperitoneal 65mg/kg (65mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 42, Pg. 253, 1931.
rabbit LD50 intravenous 40mg/kg (40mg/kg)   Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 44, Pg. 221, 1955.
rabbit LD50 oral 175mg/kg (175mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 42, Pg. 253, 1931.
rabbit LDLo parenteral 60mg/kg (60mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION Journal of Pharmacology and Experimental Therapeutics. Vol. 41, Pg. 465, 1931.
rabbit LDLo rectal 65mg/kg (65mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 60, Pg. 189, 1937.
rat LD50 intraduodenal 39mg/kg (39mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 180, Pg. 155, 1969.
rat LD50 intraperitoneal 36mg/kg (36mg/kg)   Food and Cosmetics Toxicology. Vol. 3, Pg. 597, 1965.
rat LD50 intravenous 65mg/kg (65mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 135, Pg. 213, 1962.
rat LD50 oral 118mg/kg (118mg/kg)   Toxicology and Applied Pharmacology. Vol. 21, Pg. 315, 1972.
rat LD50 subcutaneous 47mg/kg (47mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 180, Pg. 155, 1969.
women TDLo oral 60mg/kg (60mg/kg) BEHAVIORAL: WAKEFULNESS Journal of Laboratory and Clinical Medicine. Vol. 29, Pg. 265, 1944.